Product NDC: | 65862-224 |
Proprietary Name: | Sertraline Hydrochloride |
Non Proprietary Name: | Sertraline Hydrochloride |
Active Ingredient(s): | 20 mg/mL & nbsp; Sertraline Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | SOLUTION, CONCENTRATE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 65862-224 |
Labeler Name: | Aurobindo Pharma Limited |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078861 |
Marketing Category: | ANDA |
Start Marketing Date: | 20081031 |
Package NDC: | 65862-224-60 |
Package Description: | 1 BOTTLE in 1 CARTON (65862-224-60) > 60 mL in 1 BOTTLE |
NDC Code | 65862-224-60 |
Proprietary Name | Sertraline Hydrochloride |
Package Description | 1 BOTTLE in 1 CARTON (65862-224-60) > 60 mL in 1 BOTTLE |
Product NDC | 65862-224 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Sertraline Hydrochloride |
Dosage Form Name | SOLUTION, CONCENTRATE |
Route Name | ORAL |
Start Marketing Date | 20081031 |
Marketing Category Name | ANDA |
Labeler Name | Aurobindo Pharma Limited |
Substance Name | SERTRALINE HYDROCHLORIDE |
Strength Number | 20 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |